Who is sponsoring NCT03575845?

NCT03575845 is sponsored by Mount Mary University.

What drugs are being tested in NCT03575845?

Interventions in NCT03575845: Occupational Therapy Informed Yoga.

What condition does NCT03575845 study?

NCT03575845 studies Breast Neoplasm Female.

Is NCT03575845 still recruiting?

NCT03575845 is currently completed. Last updated 3 July 2018.

Last reviewed 2018-07-03 · How we verify

NCT03575845

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Yoga on Barriers to Occupational Engagement in African American Breast Cancer Survivors

Completed NA Last updated 3 July 2018

What this trial tests

NA trial testing Occupational Therapy Informed Yoga in Breast Neoplasm Female in 17 participants. Completed in 24 October 2015.

Timeline

5 June 2015

Primary endpoint
16 July 2015

24 October 2015

Quick facts

Lead sponsor	Mount Mary University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	17
Start date	5 June 2015
Primary completion	16 July 2015
Estimated completion	24 October 2015

Drugs / interventions tested

Occupational Therapy Informed Yoga

Conditions studied

Breast Neoplasm Female — all drugs for Breast Neoplasm Female →

Sponsor

Mount Mary University

Who can join

18 and older, female only, with Breast Neoplasm Female. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study was to determine if occupational therapy informed yoga could decrease barriers to occupational engagement in African American breast cancer survivors. .

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Breast Neoplasm Female

Currently open trials in the same condition.

NCT07465523 — A Novel Approach in the Evaluation of Breast Masses With Doppler US · recruiting
NCT06711523 — Study Evaluating PEG-G-CSF Injectionin Preventing Neutropenia After Chemotherapy · Phase 3 · active not recruiting
NCT05277935 — Wearable Enhanced Fitness Tracking for Metastatic Breast Cancer Patients Using Endocrine Treatment and Palbociclib · NA · recruiting
NCT06234137 — A Prospective, Open, Multicenter Single-arm Clinical Studie of Docetaxel, Carboplatin Combined With Inetetamab and Pyrot · NA · recruiting
NCT04812652 — Digitally Distributed Yoga for Women Treated for Breast Cancer · NA · active not recruiting

Other Mount Mary University trials

Trials by the same sponsor.

NCT03575624 — Changing Health Behaviors to Manage Chronic Conditions in Community-dwelling African American Breast Cancer Survivors · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03575845 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Mount Mary University
Last refreshed: 3 July 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03575845.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing